Aviva’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $85.8M | Buy |
|
|||||
|
2025
Q1 | $87.6M | Buy |
|
|||||
|
2024
Q4 | $62.6M | Buy |
|
|||||
|
2024
Q3 | $58.1M | Buy |
|
|||||
|
2024
Q2 | $57.1M | Buy |
|
|||||
|
2024
Q1 | $41M | Sell |
|
|||||
|
2023
Q4 | $51.7M | Buy |
|
|||||
|
2023
Q3 | $38.1M | Buy |
|
|||||
|
2023
Q2 | $35.5M | Sell |
|
|||||
|
2023
Q1 | $49.3M | Buy |
|
|||||
|
2022
Q4 | $44M | Sell |
|
|||||
|
2022
Q3 | $49.5M | Sell |
|
|||||
|
2022
Q2 | $54.9M | Buy |
|
|||||
|
2022
Q1 | $38.6M | Buy |
|
|||||
|
2021
Q4 | $20.5M | Sell |
|
|||||
|
2021
Q3 | $18.5M | Buy |
|
|||||
|
2021
Q2 | $19.4M | Buy |
|
|||||
|
2021
Q1 | $18.7M | Sell |
|
|||||
|
2020
Q4 | $20.6M | Buy |
|
|||||
|
2020
Q3 | $22.8M | Sell |
|
|||||
|
2020
Q2 | $25.1M | Sell |
|
|||||
|
2020
Q1 | $21.7M | Buy |
|
|||||
|
2019
Q4 | $19.7M | Sell |
|
|||||
|
2019
Q3 | $15.3M | Sell |
|
|||||
|
2019
Q2 | $17.3M | Sell |
|
|||||
|
2019
Q1 | $17.7M | Buy |
|
|||||
|
2018
Q4 | $16M | Sell |
|
|||||
|
2018
Q3 | $23.7M | Sell |
|
|||||
|
2018
Q2 | $21.6M | Sell |
|
|||||
|
2018
Q1 | $20.9M | Sell |
|
|||||
|
2017
Q4 | $21.1M | Sell |
|
|||||
|
2017
Q3 | $24M | Buy |
|
|||||
|
2017
Q2 | $19.9M | Buy |
|
|||||
|
2017
Q1 | $16.7M | Sell |
|
|||||
|
2016
Q4 | $11.9M | Buy |
|
|||||
|
2016
Q3 | $13.1M | Buy |
|
|||||
|
2016
Q2 | $12.7M | Buy |
|
|||||
|
2016
Q1 | $10.8M | Buy |
|
|||||
|
2015
Q4 | $16.9M | Sell |
|
|||||
|
2015
Q3 | $14.1M | Sell |
|
|||||
|
2015
Q2 | $16.9M | Buy |
|
|||||
|
2015
Q1 | $15.2M | Buy |
|
|||||
|
2014
Q4 | $11.5M | Sell |
|
|||||
|
2014
Q3 | $10.9M | Sell |
|
|||||
|
2014
Q2 | $9.18M | Buy |
|
|||||
|
2014
Q1 | $6.84M | Buy |
|
|||||
|
2013
Q4 | $6.83M | Buy |
|
|||||
|
2013
Q3 | $6.34M | Sell |
|
|||||
|
2013
Q2 | $27M | Buy |
|